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Abstract 
Congenital heart disease is an important cause of infant mortality and disability. The frequency,
spectrum and contributory risk factors for significant cardiovascular malformations among live-births
was retrospectively evaluated at the Aga Khan University Hospital. Of a total of 8331 live births
between July, 1987 and December, 1992 34babieswere diagnosed to have congenital heart diseasein the
neonatalperiod giving a prevalence of 4 per 1000 live births. Ventricular septal defects was the most
common (n=10, 29%) abnormality. Eight cases had associated chromosomal abnormality, the most
common being Trisomy 21. Maternal abortions, still-births, consanguinity and diabetes mellitus were
not found to be significant risk factors for congenital heart disease in this survey (JPMA 47: 78,1997).
Introduction 
Congenital heart disease (CHD) includes major structural malfonnations of the heart and/or major
vessels present at, or persisting abnormally after birth1. The prevalence of congenital heart disease
(CHD) atbirthhasbeen relatively variable at 4.05 to 10.4 cases per 1000 live births in different surveys
using avariety of case discovery methods2-4, In a meta analysis using only cases “confinned” by
autopsy, surgery, cardiac catheterization or echocardiography, the birth prevalence was nearly constant
at approximately 4 per 1000 live births5.
Despite the importance of CHD as a cause of infant mortality and disability, the exact etiology of these
anomalies remans mostly unknown6. Approximately 80-90% of these cases have a genetic-
environmental interaction7, Classic Mendelian single gene defects account for about 3-5% and
chromosomal defects for 5-8% cases of CHD. The most common defect is Trisomy 21, but Trisomy.
13, Trisomy 18 and the 45X0 (Turners syndrome) can also be involved2-7. Pnmaiy environmental
factors are the etiological cause in the remaining 2-3% cases7. These include the drug Thalidomide and
rubella virus as the classical causes of CHD. As a result of cultural and religious factors not permitting
autopsies, lack of population studies and limited resources very few reports on, CHD am available,
from Asian and African countries including Pakistan. Yet it is important to find out the possible role of
various environmental and -genetic factors and to determine antenatal risk factors for CHD in our
population. Similarly information on the prevalence and spectrum of CHD is necessary to develop
effective paediatnc cardiology services for their management and treatment among Pakistani newborn
infants.
Methodology 
Retrospective analysis of all live births with CHD delivered at the Aga Khan University Hospital
between July, 1987 and December, 1992 were analysed and case control analysis done on CHD cases
without chromosomal anomalies. All live births who during the neonatal period (initial hospitalization
and first postnatal visit, between 2 1-28 days of age) were clinically suspected to have CHD and
subsequently confirmed to have a significant cardiovascular malformation by echocardiography were
included. For each case, a control was identified as the next consecutive live birth without any
congenital malformation, matched for sex and weight. Premature infants with patent ductus arteriosus
(PDA) were excluded from the study. Maternal and neonatal data was collected from the medical files
using data extraction sheets. Data was analyzed using the statistical package for social sciences (SPSS)
(Windows 6.1 1994 Chicago, USA). Umvariate methods were used forcalculationof odds ratio and
corresponding 96% confidence intervals and analysis of variance employing the two-tailed students t-
test was used for evaluation of continuous data, Significance was set at 5%.
Results 
A total of 34 new borns were diagnosed to have a significant congenital heart disease (CHD) during the
neonatal period out of a total of 8331 live births. The prevalence of CHD in neonates was found to be 4
per 1000 live births. The most common cardiovascular malformation detected was ventricular septal
defect(VSD) (n=10) followed by patent ductus arteriosus (PDA) (n=7) (Table I).
There were 8 cases with chromosomal abnormalities, of which there were 7 cases of Trisomy 21 and 1
ofTrisomy 18. Congenital rubella syndrome was the etiological cause in 2 cases, while in the remaining
cases no definite etiology could be ascertained.
Table II lists maternal risk factors and neonatal characteristics at birth for non-chromosomal
cardiovascular malformations. No association of CHD was found with antenatal conditions such as
abortions, still-births and maternal diabetes mellitus. Consanguinity was also not significantly
associated with cardiovascular malformations. Affected newborn infants were morç likely to have
lowerapgar scores of 1 and 5 minutes at birth however, there was no significant difference in the birth
weight or gestation of the cases.
Discussion 
The 4 per 1000 live birth prevalence of CHD among Pakistani newborn infants delivered at this
hospital may be considered as an under-estimate of the actual figure. Firstly, many cases of CHD such
as those with minimal pulmonic stenosis or very small ventricular or atrial defects, may not become
clinically evident in the neonatal period and therefore not be diagnosed by ordinary clinical
examination2. Secondly only 40-50% of cases with CHD are diagnosed in the first week and 50-60% in
the first month after birth2. Since our study only included cases diagnosed during the neonatal period, a
significant number of cases which were diagnosed after the first month of birth, may have been missed.
Another important factor in assessing the actual incidence of CHD is the fact that the incidence appears
to be approximately 5 times higher in still-born fetuses and abortuses than in live born infants2.
However, the malformations in abortuses and intrauterine deaths are usually excluded from estimates
of prevalence of CHD in birth cohorts. By not considering the incidence of CHD in pre-natal deaths, in
children with minimal CHD and those cases detected after the neonatal period, the potential importance
of genetic and chromosomal factors is grossly under-estimated. At the same time the importance of
environmental teratogens may be incorrectly assessed. However, even though this figure may be an
under-estimate of the actual incidence, it still represents a significant thsease’burden on the health
system.
The spectrum and incidence of various cardiac lesions in this series is similar to what has been reported
elsewhere. According to Hoffman2 various social, religious and economic factors may prevent infant
receiving medical care and autopsies in several Asian and African countries. Therefore, serious cardiac
lesions that cause early death and very mild lesions may be under represented in reported series from
these countries. This may be one of the possible explanations for the difference in distribution of
various cardiac lesions in this study as compared to other reports. For example, the difference in the
incidence of the most common lesion i.e., ventricular septal defect (VSD) between different reports, is
because clinically inevident defects, only detectable by invasive methods, were included in several of
the studies. Differences in the incidence rate of rare lesions can also be due to relatively small numbers
of these lesions in each series. However, prevalence rate of CHD reported here is similar to the figures
cited from a population based study of live births by Ferencz et al14, although lower figures have been
reported among a review of over a million live births fmm the New England Regional Infant Cardiac
Programme15. The prevalence of cardiovascular malformations in Trisomy 21 is reported to be about
40~50%8-10. While the incidence of Trisomy 21 in reported series of children with CHD ranged from
3.2 to 10.4%, none of them mentioned maternal age, in any detail2. In this study of live births with
CHD, 20% of the cases had Trisomy 21, whereas the proportion of mothers older than 35 years of age
was 6% of the total maternal population. It is therefore difficult to attribute the greater proportion of
cases with CHD due to Trisomy 21 in this sample, to agreater number of elderly mothers orto
alternative undetermined factors.
In this study certain maternal conditions of the cases without chromosomal abnormalities during the
previous and current pregnancies were investigated to evaluate their association with CHD. Of these
factors maternal abortions, still-births, consanguinity and maternal diabetes inellitus16 were not
associated with a significant risk of CHD. However, newborns with CHD were overall found to be
more depressed at birth in our study in comparison with controls. Several other workers have also
failed to identify any clear etiological factors for CHD17. The intake of drugs during early pregnancy is
hazardous because they are responsible for 1.5% of all congenital anomalies and most drugs have not
been tested in humans5. Known cardiogenic teratogens include lithium, hydantoin, retinoic acid,
amphetamines and maternal hormonal therapy5. Several reports have suggested that amphetamines and
salicylate intakes could also cause cardiovascular malformations15,16. Maternal drug intake could not
be ascertained as a possible risk factor in this series because of incomplete documentation in the
medical record. It is important to monitor and document all maternal drug intake during the antenatal
period and to avoid unnecessary use of drugs, especially during the first trimester. This survey from a
well defined obstetric population with neonatal follow-up suggests that CHD represents a significant
burden of congenital malformations. The present data does represent some differences from the pattern
of congenital heart disease among referred children in other series fmrn Pakistan, which contained
mostly older children18,19. Thus rates of PDA are proportionately higher in this series than tetralogy of
Fallot. Considering the additional children who acquire heart disease from rheumatic fever each year,
these data represent a substantial burden of heart disease in the paediatric age group. This has important
implications in the future development of paediatric cardiac services including the training of
pediatricians inPakistan.It is also essential to carry out further multi-center and population based
studies to determine and validate various maternal and neonatal risk factors for CHD in Pakistani
population at large.
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